Aethlon Medical, Inc.
AEMD · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2,492 | $4,464 | $14,014 |
| - Cash | $5,853 | $3,765,154 | $5,501 | $4,825 |
| + Debt | $172 | $573,852 | $650 | $725 |
| Enterprise Value | – | -$3,188,810 | -$387 | $9,913 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$153 | -$155 | -$84 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1,334 | -$1,607 | -$6,161 | -$1,731 |
| % Margin | – | – | – | – |
| Net Income | -$1,487 | -$1,762 | -$6,255 | -$1,755 |
| % Margin | – | – | – | – |
| EPS Diluted | -3.74 | -8.5 | -40.1 | -8.6 |
| % Growth | 56% | 78.8% | -366.3% | – |
| Operating Cash Flow | -$1,659 | -$1,714,937 | -$1,673 | -$2,011 |
| Capital Expenditures | -$0 | $0 | $2 | -$2 |
| Free Cash Flow | -$1,659 | -$1,714,937 | -$1,670 | -$2,013 |